top of page

Kyverna's CEO on B-cell depletion and CD19 CAR-T for autoimmune conditions

Peter Maag describes how Kyverna has been focused on this area for five years and today has clinical experience in diseases as varied as lupus and multiple sclerosis.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page